- Undergraduate Education
- Hubei University of Chinese Medicine (Wuhan), China. MD, Medicine, 1992
- Graduate Education
- Tongji Medical University (Wuhan), China. Master of Medical Science, 1995
- Beijing Medical University, China. PhD in Medical Science, 1998
- Junior Faculty Award, American Diabetes Association, 2010
- Research Award, Minnesota Medical Foundation, 2004
- Travel Award, Dept. of BMBB, the University of Minnesota, 2001
- Pilot & Feasibility Research Award, Minnesota Obesity Center, 2002, 2005
- Travel Award, The Center for Diabetes Research, University of Minnesota, 2001
- Courses Taught
- NUTR 470: Nutrition and Physiological Chemistry
- NUTR 681: Nutrition Seminar
The long-term goal of Dr. Wu’s research program is to elucidate the mechanisms underlying the pathogenesis of obesity and overnutrition-associated metabolic diseases including insulin resistance, diabetes, and fatty liver disease so that novel dietary and/or pharmacological approaches can be developed for preventing and/or treating metabolic diseases. Using molecular, cellular, and integrative approaches, the Wu lab is focused on investigating the interaction between metabolism and inflammation.
Obesity, insulin resistance, diabetes, and fatty liver disease
- Meadows, V, Baiocchi, L, Kundu, D, Sato, K, Fuentes, Y, Wu, C et al.. Biliary Epithelial Senescence in Liver Disease: There Will Be SASP. Front Mol Biosci. 2021;8 :803098. doi: 10.3389/fmolb.2021.803098. PubMed PMID:34993234 PubMed Central PMC8724525.
- Wan, Y, Li, X, Slevin, E, Harrison, K, Li, T, Zhang, Y et al.. Endothelial dysfunction in pathological processes of chronic liver disease during aging. FASEB J. 2022;36 (1):e22125. doi: 10.1096/fj.202101426R. PubMed PMID:34958687 .
- Wang, X, Rao, H, Liu, F, Wei, L, Li, H, Wu, C et al.. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Cells. 2021;10 (12):. doi: 10.3390/cells10123300. PubMed PMID:34943809 PubMed Central PMC8699427.